WASHINGTON, June 13 /PRNewswire-FirstCall/ -- Abbott announced today the presentation of results from a new study designed to assess the accuracy of the FreeStyle Navigator(TM) Continuous Glucose Monitoring System for people with diabetes. The study met its primary endpoint of demonstrated accuracy and stability over five days of wear.
